Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Gregory D Huhn
Daclatasvir and Sofosbuvir With Ribavirin for 24 Weeks in Chronic Hepatitis C Genotype-3-Infected Patients With Cirrhosis: A Phase III Study (ALLY-3C)
Antiviral Therapy
Infectious Diseases
Pharmacology
Related publications
Sofosbuvir Plus Daclatasvir With or Without Ribavirin in 551 Patients With Hepatitis C-Related Cirrhosis, Genotype 4
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Daclatasvir Plus Sofosbuvir With or Without Ribavirin in Patients With Chronic Hepatitis C Genotype 3a in Pakistani Population - A Real World Experience
Pakistan Journal of Medical Sciences
Medicine
Sofosbuvir, Ribavirin and Pegylated Interferon for a Daclatasvir-Resistent Genotype 3 Hepatitis C Virus: Case Report and Review
Revista do Instituto de Medicina Tropical de Sao Paulo
Medicine
Infectious Diseases
Efficacy and Safety of Generic Daclatasvir + Sofosbuvir ± Ribavirin in Treatment of Genotype 3 Infected Hepatitis C Patients - A Real Life Experience From Pakistan
Hepatoma Research
Sofosbuvir and Ribavirin for Hepatitis C in Patients With HIV Coinfection
JAMA - Journal of the American Medical Association
Medicine
Efficacy and Safety of Ribavirin With Sofosbuvir Plus Ledipasvir in Patients With Genotype 1 Hepatitis C: A Meta-Analysis
Digestive Diseases and Sciences
Physiology
Gastroenterology
A Randomized, Controlled Study of Peginterferon Lambda-1a/Ribavirin ± Daclatasvir for Hepatitis C Virus Genotype 2 or 3
SpringerPlus
Multidisciplinary
Secondary Occult Hepatitis C Virus Infection (HCV) in Chronic HCV Patients After Treatment With Sofosbuvir and Daclatasvir
International Journal of Current Microbiology and Applied Sciences
Safety and Efficacy of Simeprevir/Sofosbuvir in Hepatitis C-Infected Patients With Compensated and Decompensated Cirrhosis
Hepatology
Medicine
Hepatology
